# Nucleonics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nucleonics

- Industry: Biotechnology
- Headquarters: Horsham, US
- Total disclosed funding: $15M
- Latest round: Series B (Aug 21, 2007)
- Investors on record: 4

## About

Based in US and founded in 2001, Nucleonics, Inc. is a biotechnology company which focuses on the development of novel RNA-interference based therapeutics for Viral as well as other diseases.

## Funding rounds

- Series B, Aug 21, 2007, $15M — Burrill & Company, New Enterprise Associates, HealthCap, SR One

## Investors

- Burrill & Company (https://capitalatlas.ai/funds/burrill-company) — Series B
- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series B
- HealthCap — Series B
- SR One (https://capitalatlas.ai/funds/sr-one) — Series B